What is nOCD?
nOCD offers live video sessions with licensed therapists specializing in Exposure and Response Prevention (ERP), the gold standard treatment for OCD. The platform aims to provide accessible and effective care, allowing individuals to regain control of their lives. By connecting patients with therapists trained by top OCD experts, nOCD addresses a critical need in mental health, leveraging technology to deliver evidence-based therapeutic interventions.
How much funding has nOCD raised?
nOCD has raised a total of $80.2M across 5 funding rounds:
Private Equity
$1M
Debt
$150K
Series A
$12M
Series B
$33M
Other Financing Round
$34M
Private Equity (2017): $1M with participation from 7 Wire Ventures
Debt (2020): $150K led by PPP
Series A (2020): $12M supported by Chicago Ventures, Meridian Street Capital, Hyde Park Angels, and 7Wire Ventures
Series B (2021): $33M featuring 7wireVentures, Health Enterprise Partners, Kaiser Permanente Ventures, Chicago Ventures, Eight Roads, and F-Prime Capital Partners
Other Financing Round (2023): $34M backed by Longitude Capital, 7wireVentures, Health Enterprise Partners, Cigna Ventures, Eight Roads Capital, and Kaiser Permanente Ventures
Key Investors in nOCD
7wireVentures
7wire Ventures is a venture capital firm that invests in early-stage digital health companies, aiming to empower consumers and revolutionize healthcare through innovative solutions.
Health Enterprise Partners
Health Enterprise Partners is a venture capital firm focused on transforming the healthcare industry by enhancing healthcare delivery and supporting innovative solutions.
Longitude Capital
Longitude Capital is a venture capital firm that invests in biotechnology, medical technology, and health solutions companies, aiming to improve patient care.
What's next for nOCD?
With the recent major strategic investment, nOCD is poised for significant expansion and further development of its platform. The company's trajectory suggests a focus on scaling its operations to reach a broader patient base and enhancing its therapeutic offerings. This latest round of financing will likely fuel advancements in its technology, further solidify its market position in the digital mental health sector, and potentially explore new treatment modalities or partnerships to combat OCD.
See full nOCD company page
